Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
1(25.0%)
Early Phase 1
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05834010Early Phase 1Completed

Feasibility Study of Using Fecal Microbiota Transplants in Anorexia Nervosa

Role: collaborator

NCT05605067Completed

Genetic Architecture of Avoidant/Restrictive Food Intake Disorder

Role: collaborator

NCT04675684Not ApplicableUnknown

Recovery-by-eHealth

Role: collaborator

NCT01569685Phase 4Completed

The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy

Role: collaborator

NCT00130455Phase 4Terminated

Treatment of Depression in the Elderly

Role: collaborator

All 5 trials loaded